?

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Found 4137 publications
Investigation Report on China Piperacillin Sodium and Tazobactam Sodium Market, 2010-2019 US$ 2,000.00

... Wyeth Pharmaceutical Co., Ltd (US), Qilu Pharmaceutical Co., Ltd, North China Pharmaceutical Group Corporation, Zhejiang Anglikang Pharmaceutical Co., Ltd and United Laboratories occupy the majority of the Chinese market, among which Wyeth Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Thrombin Market, 2010-2019 US$ 2,000.00

... thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Risedronate Sodium Market, 2010-2019 US$ 2,000.00

... Risedronate sodiums in the Chinese market are all produced by local enterprises represented by Kunming Jida Pharmaceutical Co., Ltd, Topfond, Yangtze River Pharmaceutical Group, Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd and Beijing SL Pharm, among which Kunming Jida Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Simvastatin Market, 2010-2019 US$ 2,000.00

... Pharmaceutical Co., Ltd, Merck Sharp & Dohme (UK), Guangzhou Nanxin Pharmaceutical Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Shandong Lukang Pharmaceutical Co., Ltd occupy the majority of market, among which Hangzhou MSD Pharmaceutical Co., Ltd ...

Jun, 2015 40 pages
Investigation Report on China Levofloxacin Market, 2010-2019 US$ 2,000.00

... Daiichi Sankyo Co., Ltd (Beijing), Yangtze River Pharmaceutical Group, China Resources Double Crane Pharmaceutical Co., Ltd, Santen Pharmaceutical Co., Ltd (Japan) and Zhejiang Medicine Co., Ltd. Xinchang Pharmaceutical Factory have occupied the majority of the market share, among which Daiichi Sankyo ...

Jun, 2015 40 pages
Investigation Report on China Raloxifene Market, 2010-2019 US$ 2,000.00

... bone mass or osteoporosis while this figure is 30%-50% among women aged 60 and above. Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs ...

Jun, 2015 30 pages
Investigation Report on China Sodium Ibandronate Market, 2010-2019 US$ 2,000.00

... China. Currently, sodium ibandronate market in China is mainly occupied by the following companies: Science & Technology General Company Hebei Medical University, Roche Diagnostics GmbH GE), Hencer Pharmacy and Easton Pharmaceutical Co., Ltd, among which Science & Technology General Company Hebei Medical ...

Jun, 2015 30 pages
Investigation Report on China Thymosin α1 Market, 2010-2019 US$ 2,000.00

... Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia ...

Jun, 2015 30 pages
Investigation Report on China Zoledronic Acid Market, 2010-2019 US$ 2,000.00

... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...

Jun, 2015 30 pages
Investigation Report on China Cervus and Cucumis Polypeptide Market, 2010-2019 US$ 2,000.00

... cervus and cucumis polypeptide in the Chinese market all come from the following three companies: Gloria Pharmaceuticals Co., Ltd, Heilongjiang Dilong Pharmaceutical Co., Ltd and Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Gloria Pharmaceuticals Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Alendronate Sodium Market, 2010-2019 US$ 2,000.00

... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...

Jun, 2015 30 pages
Investigation Report on China Sodium Hyaluronate Market, 2010-2019 US$ 2,000.00

... sodium hyaluronate injection is used as a joint function-improving agent for intra-articular injection on osteoarthropathy patients. Currently, only sodium hyaluronate injection ...

Jun, 2015 35 pages
Investigation Report on China Olanzapine Market, 2010-2019 US$ 2,000.00

... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...

Jun, 2015 25 pages
Investigation Report on China Paclitaxel Market, 2010-2019 US$ 2,000.00

... China paclitaxel market include Nanjing Luye Pharma Group Sike Pharmaceutical Co., Ltd, The Department of Cancer, Bristol-Myers Squibb ...

Jun, 2015 40 pages
Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019 US$ 2,000.00

... imipenem and cilastatin sodium in China competitive landscape of imipenem and cilastatin sodium in Chinese market price of imipenem and cilastatin sodium made by different enterprises in China market outlook of imipenem and cilastatin sodium in China ...

Jun, 2015 30 pages
Investigation Report on China Salmon Calcitonin Market, 2010-2019 US$ 2,000.00

... Novartis’s salmon calcitonin entered China under the trade name of Miacalcic and later salmon calcitonin made by Lisapharma ...

Jun, 2015 35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019 US$ 2,000.00

... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...

Jun, 2015 35 pages
Investigation Report on China Progesterone Market, 2010-2019 US$ 2,000.00

... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...

Jun, 2015 35 pages
Investigation Report on China Ossotide Market, 2010-2019 US$ 2,000.00

... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...

Jun, 2015 35 pages
Investigation Report on China Moxifloxacin Market, 2010-2019 US$ 2,000.00

... China are mainly produced by Nanjing Youke Pharmaceutical CO., Ltd and The Bayer Group whichowns the larger market share of over 95% for sales value in 2014. As an outstanding antibacterial drug, moxifloxacin ...

Jun, 2015 20 pages
Investigation Report on China Menotropins Market, 2010-2019 US$ 2,000.00

... Livzon Pharmaceutical, Livzon Pharmaceutical Group, Inc, Ferring Pharmaceytical Co., Ltd (Germany), Ma’anshan Fengyuan Pharmaceutical Co., Ltd, Yantai North Pharmaceutical Co., Ltd and Shanghai Livzon Pharmaceutical Co., Ltd, among which Shanghai Livzon Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Investigation Report on China Levothyroxine Market, 2010-2019 US$ 2,000.00

... Thyroid hormones (TH) have the greatest effect of promoting growth on five-month-old babies or younger ones. Without thyroid hormones ... Levothyroxine enjoys a vast demand in China. Merck (Germany), Berlin-Chemie AG (Germany) and China Associated Pharmaceutical all take up certain market share, among which Merck ...

Jun, 2015 20 pages
Investigation Report on China Glucosamine Market, 2010-2019 US$ 2,000.00

... Glucosamine is of great demand in China. Most of the market share has been occupied by Shanxi Zhongyuanwei Pharmaceutical Co., Ltd, Bright Future Pharmaceutical Laboratories Limited, Rottapharm Ltd, Zhejiang Hisun Pharmaceutical Co., Ltd ...

Jun, 2015 35 pages
Investigation Report on China Ganglioside Market, 2010-2019 US$ 2,000.00

... ganglioside sodium in China, among which Qilu Pharmaceutical Co., Ltd, Medical University Pharmaceutical Co., Ltd, Beijing Science Sun Pharmaceutical Co., Ltd, Changchun Xiangtong Pharmaceutical Co., Ltd and Wellso Pharmaceutical take the lion’s share. The marketing of domestic ganglioside ...

Jun, 2015 35 pages
Investigation Report on China Flurbiprofen Market, 2010-2019 US$ 2,000.00

... Beijing Tide Pharmaceutical Co., Ltd and MIKASA SEIYAKU CO.,LTD, the former having the larger market share of 99% for sales value in 2014. The market size of flurbiprofen in China ...

Jun, 2015 20 pages
Investigation Report on China Etanercept Market, 2010-2019 US$ 2,000.00

... etanercept in the Chinese market is monopolized by Boehringer Ingelheim (Germany). According to CRI’s market survey, the price range of 25 mg (one injection per package) etanercept ...

Jun, 2015 20 pages
Investigation Report on China Entecavir Market, 2010-2019 US$ 2,000.00

... hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatitis B. ... entecavir in China rose from CNY 30 million in 2006 to CNY 1.207 billion in 2014 and CAGR during this period reached up to 55%. Entecavir made by Sino-American Shanghai Squibb Pharmaceuticals Ltd ...

Jun, 2015 30 pages
Investigation Report on China Cefathiamidine Market, 2010-2019 US$ 2,000.00

... Guangzhou Baiyunshan Pharmaceutical General Factory, cefathiamidine has been written into the Chinese Pharmacopoeia (2005). Ever since its marketing in 2000, the sales value of cefathiamidine ...

Jun, 2015 35 pages
Investigation Report on China Bromhexine Market, 2010-2019 US$ 2,000.00

... bromhexine in the Chinese market mainly comes from local enterprises like Jiangxi Kelun Pharmaceutical Co., Ltd, Jincheng Haisi Pharmaceutical Co., Ltd and Shanxi Powerdone Pharmaceutical Co., Ltd, Shijiazhuang No.4 Pharmaceutical Co., Ltd ...

Jun, 2015 30 pages
Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts US$ 8,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015 ...

Jun, 2015 313 pages
Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts US$ 6,500.00

... as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market 2015: Supplier ...

Jun, 2015 291 pages
Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2015: Supplier Shares and Country Forecasts US$ 8,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market 2015” is a unique ...

Jun, 2015 318 pages
Future Horizons and Growth Strategies in the European Drugs of Abuse Testing Market 2015: Supplier Shares and Country Forecasts US$ 6,500.00

... , such as specimen preparation devices, controls, calibrators and others. Future Horizons and Growth Strategies in the European Drugs of Abuse Testing Market 2015” is a unique ...

Jun, 2015 300 pages
Europe Prebiotics (Nutraceuticals) Market by Application (Functional Food, Functional Beverages, Dietary Supplements, Animal Feed, & Personal Care) by Country (Germany, France, Russia,... US$ 2,650.00

... popular among the consumers in turn benefitting the prebiotics (nutraceuticals) ingredients industry. In this report, the Europe prebiotics (nutraceuticals) market has been broadly discussed by its application ... engaged in market strategies such as mergers & acquisitions, joint venture, new product development and expansion to increase the market share in the Europe prebiotics (nutraceuticals) market. Reasons to Buy ...

Jun, 2015 83 pages
Global Colorectal Cancer Drugs Market 2015-2019 US$ 3,000.00

... four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies. Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR ... market at large, as well as the key trends that are emerging in the market. Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market ...

Jun, 2015 125 pages
Investigation Report on China Recombinant Factor Ⅷ Market, 2010-2019 US$ 2,000.00

... and treatment of hemophilia have a huge market. Apart from Bayer Schering, Baxter and Wyeth also make recombinant factor Ⅷ too. After entering China, recombinant factor Ⅷ develops ... report: sales status of recombinant factor Ⅷ in China price of recombinant factor Ⅷ in Chinese market major manufacturers of recombinant factor Ⅷ in Chinese market share of dosage forms of recombinant factor Ⅷ in China market outlook of recombinant factor Ⅷ in China The author suggests ...

Jun, 2015 30 pages
Investigation Report on China Octreotide Market, 2010-2019 US$ 2,000.00

... octreotide in China market share of manufacturers of octreotide in China price of octreotide in Chinese market major manufacturers of octreotide in Chinese market market outlook of octreotide in China ...

Jun, 2015 30 pages
Investigation Report on China Methylprednisolone Market, 2010-2019 US$ 2,000.00

... varieties of steroid’s APIs, half are made in China. As a variety performing well in hospitals in recent years, methylprednisolone, ... methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn). The APIs and preparations of methylprednisolone ...

Jun, 2015 30 pages
Investigation Report on China Liraglutide Market, 2011-2019 US$ 2,000.00

... diabetes incidence in China. Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, was developed by Novo Nordisk in 2008 to treat diabetes. Liraglutide, a derivative attained by attaching a fatty acid molecule to GLP-1 molecule, can reduce the HbA1c level and weight of type 2 diabetes ...

Jun, 2015 25 pages
Investigation Report on China Ezetimibe Market, 2010-2019 US$ 2,000.00

... estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive ... this report: market size of ezetimibe in China price of ezetimibe in Chinese market market outlook of ezetimibe in China The author suggests the following groups ...

Jun, 2015 20 pages
Investigation Report on China Edaravone Market, 2010-2019 US$ 2,000.00

... Cerebrovascular disease is one of the three principal diseases that can cause people to death. Acute cerebral infarction which occupies 70% of cerebrovascular disease ...

Jun, 2015 30 pages
Investigation Report on China Doxofylline Market, 2010-2019 US$ 2,000.00

... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...

Jun, 2015 30 pages
Investigation Report on China Desloratadine Market, 2010-2019 US$ 2,000.00

... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...

Jun, 2015 30 pages
Investigation Report on China Celecoxib Market, 2010-2019 US$ 2,000.00

... the market. In Sep. 2000, celebrex (celecoxib capsule) made by Pfizer Inc was approved by CFDA to enter China. Celecoxib develops fast then, ... celecoxib in Chinese market market outlook of celecoxib in China The author suggests the following groups of people purchase this report: manufacturers of NSAIDs ...

Jun, 2015 20 pages
Investigation Report on China Capecitabine Market, 2010-2019 US$ 2,000.00

... name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer ...

Jun, 2015 30 pages
Vitamin D Market by Analog (Vitamin D2 & Vitamin D3), Application (Functional Food & Beverage, Pharmaceuticals, Feed & Pet Food, and Personal Care), End–User (Children, Adult, and... US$ 4,650.00

... on the Vitamin D market. The research study categorizes the market on the basis of analog, application, end user, and region. Vitamin D market On the basis of analog, the market was sub-segmented as follows: Vitamin D2 Vitamin D3 On the basis of application, the market ...

Jun, 2015 179 pages
Genome-Based Drug Markets in China US$ 4,000.00

China's demand for Genome-Based Drug has grown at a fast pace in the past decade. In the next ... market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for ...

Jun, 2015 212 pages
Global Depression Drugs Market 2015-2019 US$ 3,000.00

... depression, as mentioned below: Tricyclic antidepressants Serotonin-norepinephrine reuptake inhibitors Selective serotonin reuptake inhibitors Monoamine oxidase inhibitors Others Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The ...

Jun, 2015 107 pages
Asthma Drugs Market in the US 2015-2019 US$ 3,000.00

... classes of drugs used to treat asthma, which include: Bronchodilators Leukotriene antagonists Mast cell stabilizers Immunosuppressants Combination of LABA/ICS Technavio's report, Asthma Drugs Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market ...

Jun, 2015 103 pages
Vortioxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) US$ 600.00

... Vortioxetine Indications: Treament of generalised anxiety disorder; Treatment of major depressive disorder Innovator: Takeda (Brintellix); Lundbeck (Trintellix) Country Coverage: Australia Canada France Germany Great Britain Italy Japan Spain USA Please note that 51 country ...

Jun, 2015
1 2 3 4 5 >
Skip to top